Nature Communications (Dec 2020)

Receptor-targeted engineered probiotics mitigate lethal Listeria infection

  • Rishi Drolia,
  • Mary Anne Roshni Amalaradjou,
  • Valerie Ryan,
  • Shivendra Tenguria,
  • Dongqi Liu,
  • Xingjian Bai,
  • Luping Xu,
  • Atul K. Singh,
  • Abigail D. Cox,
  • Victor Bernal-Crespo,
  • James A. Schaber,
  • Bruce M. Applegate,
  • Ramesh Vemulapalli,
  • Arun K. Bhunia

DOI
https://doi.org/10.1038/s41467-020-20200-5
Journal volume & issue
Vol. 11, no. 1
pp. 1 – 23

Abstract

Read online

Here, the authors characterize the effects of Lactobacillus casei strains engineered to express pathogenic or non-pathogenic Listeria adhesion protein (LAP) in systemic colonization and protection against lethal Listeria monocytogenes infection in mice and show that these engineered strains can colonize the intestine and prevent dissemination of L. monocytogenes and protect against lethal infection while promoting immunomodulatory effects.